An update on microRNAs as colorectal cancer biomarkers: where are we and what’s next?
Authors:
- 28 August 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 14 (8) , 999-1021
Abstract
MiRNAs are abundant classes of small, endogenous non-coding RNAs, which inhibit the expression of target gene via post-transcriptional regulation. In addition to an important functional role miRNAs...Keywords
This publication has 248 references indexed in Scilit:
- Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cellsInternational Journal of Colorectal Disease, 2012
- MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-cateninBiochemical and Biophysical Research Communications, 2012
- MicroRNAs in Stress Signaling and Human DiseaseCell, 2012
- Prognostic Significance of miR-215 in Colon CancerClinical Colorectal Cancer, 2011
- MicroRNAs and colon and rectal cancer: Differential expression by tumor location and subtypeGenes, Chromosomes and Cancer, 2010
- High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patientsClinical & Experimental Metastasis, 2010
- Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 geneCancer, 2010
- Posttranscriptional Regulation of MicroRNA Biogenesis in AnimalsMolecular Cell, 2010
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007